MPMingu Gordon Park

Mingu Gordon Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mingu Gordon Park has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    K34 (3,3″-Dihydroxy-6′-desmethyl Terphenyllin) Promotes Hemoglobin-Supported H2O2 Decomposition and Attenuates Neurodegenerative Phenotypes in APP/PS1 Mice with Focal GiD

    by Yongmin Mason Park, Byeoung-Kyu Choi, Mingu Gordon Park, Myeongju Kim, Woojin Won, Hee Jae Shin, C. Justin Lee

    Hydrogen peroxide (H2O2) contributes to oxidative stress in Alzheimer’s disease (AD), yet conventional antioxidants that directly scavenge H2O2 have shown limited therapeutic efficacy. Here, we investigated K34 (3,3″-dihydroxy-6′-desmethyl terphenyllin), a catechol-bearing para-terphenyl isolated from the marine fungus Penicillium janthinellum 168CLC-17.1, as an indirect H2O2-decomposing agent. Complementary cell-free assays showed that K34 promoted peroxidase-dependent H2O2 decomposition, including Hb-supported H2O2 decomposition, while molecular docking predicted a plausible binding pose near the Hbβ heme pocket. In amyloid-β42 (Aβ42)-stimulated primary astrocytes, K34 reduced intracellular H2O2. In APPswe/PSEN1dE9 (APP/PS1) mice subjected to focal GFAP-inducible diphtheria toxin receptor (fGiD), systemic K34 attenuated memory impairment, preserved NeuN-positive neurons, reduced GFAP immunoreactivity, and improved hippocampal spike probability. K34 also exhibited low passive blood–brain barrier (BBB) permeability and limited inhibition of five major cytochrome P450 (CYP) isoforms under the tested conditions. These findings extend Hb-supported H2O2 decomposition to a structurally distinct marine natural product and support further evaluation of K34 as an antioxidant scaffold for modulating oxidative stress-associated neurodegenerative phenotypes.

  • Open Access

    Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease

    by Min-Ho Nam, Moonsun Sa, Yeon Ha Ju, Mingu Gordon Park, C. Justin Lee

    Monoamine oxidase-B (MAOB) has been believed to mediate the degradation of monoamine neurotransmitters such as dopamine. However, this traditional belief has been challenged by demonstrating that it is not MAOB but MAOA which mediates dopamine degradation. Instead, MAOB mediates the aberrant synthesis of GABA and hydrogen peroxide (H2O2) in reactive astrocytes of Parkinson’s disease (PD). Astrocytic GABA tonically suppresses the dopaminergic neuronal activity, whereas H2O2 aggravates astrocytic reactivity and dopaminergic neuronal death. Recently discovered reversible MAOB inhibitors reduce reactive astrogliosis and restore dopaminergic neuronal activity to alleviate PD symptoms in rodents. In this perspective, we redefine the role of MAOB for the aberrant suppression and deterioration of dopaminergic neurons through excessive GABA and H2O2 synthesis of reactive astrocytes in PD.